Evidence map›Paper›PMID 32282549›Full record

ArticleEuropean journal of gastroenterology & hepatology2021

Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.

Giuseppe Lippi, Maria Helena Santos de Oliveira, Brandon Michael Henry

Open access · greenAbstract readLetter
In one paragraph

Article in European journal of gastroenterology & hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 4 pooled it
1.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Outcomes of COVID-19 among patients with liver disease.World journal of gastroenterology · 2023
    Review
  11. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  12. Observational
  13. Observational
  14. Review
  15. Article
  16. Review
  17. SARS-CoV-2: Review of Conditions Associated With Severe Disease and Mortality.International journal of preventive medicine · 2022
    Review
  18. COVID-19 and the liver: A brief and core review.World journal of hepatology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Giuseppe LippiSection of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Maria Helena Santos de OliveiraDepartment of Statistics, Federal University of Parana, Curitiba, Brazil.
Brandon Michael HenryCardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Ohio, USA.
Cincinnati Children's Hospital Medical Center · USUniversidade Federal do Paraná · BRUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Severity of Illness IndexAdultAgedAged, 80 and overChronic DiseaseCOVID-19Global HealthHumansLiver DiseasesMiddle AgedOdds RatioPrognosisRisk AssessmentRisk Factors

Identifiers

PMID32282549
PMCPMC7690326
OpenAlexW3015585945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.